Geode Capital Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Geode Capital Management’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$193K	Buy	6,454 +1,951	+43%	+$56.9K	﹤0.01%	3929
2025 Q4	$131K	Buy	4,503 +1,761	+64%	+$35.3K	﹤0.01%	4033
2025 Q3	$45.9K	Buy	2,742 +75	+3%	+$2.45K	﹤0.01%	4309
2025 Q2	$220K	Sell	2,667 -3	-0.1%	-$195	﹤0.01%	3844
2025 Q1	$211K	Sell	2,670 -30	-1%	-$3.69K	﹤0.01%	3834
2024 Q4	$452K	Buy	2,700 +8	+0.3%	+$1.05K	﹤0.01%	3630
2024 Q3	$253K	Sell	2,692 -21	-0.8%	-$1.99K	﹤0.01%	3828
2024 Q2	$267K	Buy	2,713 +577	+27%	+$71.9K	﹤0.01%	3809
2024 Q1	$328K	Buy	2,136 +249	+13%	+$26.8K	﹤0.01%	3768
2023 Q4	$220K	Buy	1,887 +1,336	+242%	+$208K	﹤0.01%	3907
2023 Q3	$110K	Buy	551 +52	+10%	+$11.3K	﹤0.01%	4217
2023 Q2	$101K	Hold	499	–	–	﹤0.01%	4329
2023 Q1	$76.8K	Hold	499	–	–	﹤0.01%	4423
2022 Q4	$67K	Sell	499 -1	-0.2%	-$200	﹤0.01%	4515
2022 Q3	$100K	Hold	500	–	–	﹤0.01%	4579
2022 Q2	$175K	Sell	500 -23	-4%	-$9.65K	﹤0.01%	4352
2022 Q1	$305K	Hold	523	–	–	﹤0.01%	4173
2021 Q4	$479K	Hold	523	–	–	﹤0.01%	4070
2021 Q3	$653K	Buy	523 +5	+1%	+$9.7K	﹤0.01%	3902
2021 Q2	$1.64M	Sell	518 -293	-36%	-$1.16M	﹤0.01%	3356
2021 Q1	$4.99M	Buy	811 +170	+27%	+$1.23M	﹤0.01%	2789
2020 Q4	$3.65M	Buy	641 +36	+6%	+$226K	﹤0.01%	2763
2020 Q3	$3.61M	Buy	605 +102	+20%	+$595K	﹤0.01%	2576
2020 Q2	$3.13M	Buy	503 +372	+284%	+$2.52M	﹤0.01%	2594
2020 Q1	$1.27M	Buy	131 +95	+264%	+$1.49M	﹤0.01%	2912
2019 Q4	$602K	Buy	36 +2	+6%	+$33.3K	﹤0.01%	3445
2019 Q3	$555K	Hold	34	–	–	﹤0.01%	3439
2019 Q2	$740K	Buy	34 +9	+36%	+$223K	﹤0.01%	3327
2019 Q1	$700K	Buy	25 +2	+9%	+$48K	﹤0.01%	3302
2018 Q4	$347K	Buy	23 +1	+5%	+$22.4K	﹤0.01%	3497
2018 Q3	$795K	Buy	22 +3	+16%	+$92.6K	﹤0.01%	3310
2018 Q2	$558K	Buy	19 +1	+6%	+$38.9K	﹤0.01%	3397
2018 Q1	$2.44M	Buy	+18	New	+$2.19M	﹤0.01%	2656

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Geode Capital Management's YARW Position: Q1 2026 in Review

Geode Capital Management increased its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 43% in Q1 2026, buying an estimated $56.9K and bringing the position to 6,454 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #3929.

Geode Capital Management first reported a position in YARW in Q1 2018 and has held it in 33 quarters since. The position peaked at $4.99M in Q1 2021. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

Geode Capital Management held 6,454 shares of Yarrow Bioscience, Inc. Common Stock worth $193K as of Q1 2026.
Geode Capital Management bought 1,951 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $56.9K.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3929 holding.
Geode Capital Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2018 and has held it in 33 quarters since.
Geode Capital Management's Yarrow Bioscience, Inc. Common Stock position peaked at $4.99M in Q1 2021.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.